Single photon emission computed tomography myocardial imaging: Clinical applications and future directions

Minerva Cardioangiologica

Volumn 57, Issue 3, 2009, Pages 333-347

  Driver, K A ^a   Atchley, A E ^a   Kaul, P ^a   Borges Neto, S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiovascular diseases; Myocardial perfusion imaging; Tomography, emission computed, single photon

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; TECHNETIUM 99M; THALLIUM 201;

ACUTE CORONARY SYNDROME; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; EMERGENCY WARD; EXERCISE; HEART FAILURE; HEART LEFT VENTRICLE DYSSYNCHRONY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; PATIENT CARE; PATIENT SELECTION; PROGNOSIS; QUANTITATIVE DIAGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH; SYSTOLIC HEART FAILURE; VALIDATION PROCESS;

CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; EXERCISE TEST; HUMANS; MYOCARDIAL PERFUSION IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 69549105550     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Zaret BL, Strauss HW, Martin ND, Wells HP, Jr., Flamm MD, Jr. Noninvasive regional myocardial perfusion with radioactive potassium. Study of patients at rest, with exercise and during angina pectoris. N Engl J Med 1973;288:809-812
2. Schelbert HR, Phelps ME, Hoffman EJ, Huang SC, Selin CE, Kuhl DE. Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. Am J Cardiol 1979;43:209-218
3. Hendel RC, Berman DS, Cullom SJ, Follansbee W, Heller GV, Kiat H et al. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation 1999;99:2742-2749 (Pubitemid 29250019)
4. Adams GL, Shaw LK, Tuttle RH, Hanson MW, Pagnanelli R, Borges-Neto S. Prediction of mortality in patients with coronary artery disease undergoing vasodilator stress testing: a comparison between 99mTc-tetrofosmin and 99mTc-sestamibi. Nucl Med Commun 2007;28:457-463 (Pubitemid 46684195)
5. rd edition. Oxford; New York: Oxford University Press; 2003.
6. rd edition. Philadelphia, Pa.: Elsevier Mosby; 2005.
7. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455-1464 (Pubitemid 23316373)
8. Sharir T, Bacher-Stier C, Dhar S, Lewin HC, Miranda R, Friedman JD et al. Identification of severe and extensive coronary artery disease by postexercise regional wall motion abnormalities in Tc-99m sestamibi gated single-photon emission computed tomography. Am J Cardiol 2000;86:1171-1175 (Pubitemid 30847724)
9. Yamamoto A, Hosoya T, Takahashi N, Iwahara S, Munakata K. Quantification of left ventricular regional functions using ECG-gated myocardial perfusion SPECT - validation of left ventricular systolic functions. Ann Nucl Med 2006;20:449-456 (Pubitemid 44543862)
10. Lapeyre AC, 3rd, Klodas E, Rogers PJ, Sinak LJ, Hammell TC, O'Connor MK et al. Quantitation of regional ejection fractions using gated tomographic imaging with 99mTc-sestamibi. Chest 2005;127:778-786
11. Ward RP, Gundeck EL, Lang RM, Spencer KT, Williams KA. Overestimation of postischemic myocardial stunning on gated SPECT imaging: correlation with echocardiography. J Nucl Cardiol 2006;13:514-520
12. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman D et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging - executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003;108:1404-1418
13. Hendel RC, Bateman TM, Cerqueira MD, Iskandrian AE, Leppo JA, Blackburn B et al. Initial clinical experience with regadenoson, a novel selective A2A agonist for pharmacologic stress single-photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol 2005;46:2069-2075 (Pubitemid 41713594)
14. Iskandrian AE, Bateman TM, Belardinelli L, Blackburn B, Cerqueira MD, Hendel RC et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007;14:645-658 (Pubitemid 47355078)
15. Udelson JE, Heller GV, Wackers FJ, Chai A, Hinchman D, Coleman PS et al. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging. Circulation 2004;109:457-464 (Pubitemid 38168506)
16. Yamagishi H, Akioka K, Hirata K, Sakanoue Y, Toda I, Yoshiyama M et al. Dobutamine stress electrocardiography-gated Tc-99m tetrofosmin SPECT for detection of viable but dysfunctional myocardium. J Nucl Cardiol 2001;8:58-67. (Pubitemid 32242049)
17. Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999;130:719-728
18. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989;80:87-98. (Pubitemid 19178641)
19. Detrano R, Gianrossi R, Froelicher V. The diagnostic accuracy of the exercise electrocardiogram: a meta-analysis of 22 years of research. Prog Cardiovasc Dis 1989;32:173-206. (Pubitemid 19274895)
20. Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol 2007;49:227-237 (Pubitemid 46054393)
21. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989;14:1477-1486 (Pubitemid 19279047)
22. Mark DB, Shaw L, Harrell FE, Jr., Hlatky MA, Lee KL, Bengtson JR et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849-853
23. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-914 (Pubitemid 26074827)
24. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793-801. (Pubitemid 34987553)
25. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-543 (Pubitemid 28090682)
26. Mazzanti M, Germano G, Kiat H, Friedman J, Berman DS. Fast technetium 99m-labeled sestamibi gated single-photon emission computed tomography for evaluation of myocardial function. J Nucl Cardiol 1996;3:143-149 (Pubitemid 26134970)
27. Borges-Neto S, Javaid A, Shaw LK, Kong DF, Hanson MW, Pagnanelli RA et al. Poststress measurements of left ventricular function with gated perfusion SPECT: comparison with resting measurements by using a same-day perfusion-function protocol. Radiology 2000;215:529-33. (Pubitemid 30237856)
28. Leslie WD, Tully S A, Yogendran MS, Ward LM, Nour KA, Metge CJ. Prognostic value of lung sestamibi uptake in myocardial perfusion imaging of patients with known or suspected coronary artery disease. J Am Coll Cardiol 2005;45:1676-1682 (Pubitemid 40704506)
29. Shaw LJ, Hendel RC, Heller GV, Borges-Neto S, Cerqueira M, Berman DS. Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT. J Nucl Cardiol 2008;15:762-773
30. Marwick TH, Shaw LJ, Lauer MS, Kesler K, Hachamovitch R, Heller GV et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 1999;106:172-178
31. Piccini JP, Horton JR, Shaw LK, Al-Khatib SM, Lee KL, Iskandrian AE et al. Single-photon emission computed tomography myocardial perfusion defects are associated with an increased risk of all-cause death, cardiovascular death, and sudden cardiac death. Circulation Cardiovascular Imaging. 2008;1:180-188
32. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-2907 (Pubitemid 36736630)
33. Amanullah AM, Heo J, Acio E, Narula J, Iskandrian AE. Predictors of outcome of medically treated patients with left main/three-vessel coronary artery disease by coronary angiography. Am J Cardiol. 1999;83:445-8, A9. (Pubitemid 29066508)
34. Dakik HA, Wendt JA, Kimball K, Pratt CM, Mahmarian JJ. Prognostic value of adenosine Tl-201 myocardial perfusion imaging after acute myocardial infarction: results of a prospective clinical trial. J Nucl Cardiol 2005;12:276-283 (Pubitemid 40790402)
35. Mahmarian JJ, Shaw LJ, Filipchuk NG, Dakik HA, Iskander SS, Ruddy TD et al. A multinational study to establish the value of early adenosine technetium-99m sestamibi myocardial perfusion imaging in identifying a low-risk group for early hospital discharge after acute myocardial infarction. J Am Coll Cardiol 2006;48:2448-57.
36. Brown KA, Heller GV, Landin RS, Shaw LJ, Beller GA, Pasquale MJ et al. Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 1999;100:2060-2066
37. Kaul S, Senior R, Firschke C, Wang XQ, Lindner J, Villanueva FS et al. Incremental value of cardiac imaging in patients presenting to the emergency department with chest pain and without ST-segment elevation: a multicenter study. Am Heart J 2004;148:129-136 (Pubitemid 38900492)
38. Kawahito M, Kondo M, Abe Y, Sakata J, Ikeda T, Maeba H et al. [Usefulness of technetium-99m tetrofosmin single-photon emission computed tomography for short-term risk stratification in patients with acute chest pain in the emergency room]. J Cardiol 2003;42:147-154
39. Kapetanopoulos A, Ahlberg AW, Taub CC, Katten DM, Heller GV. Regional wall-motion abnormalities on post-stress electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomography imaging predict cardiac events. J Nucl Cardiol 2007;14:810-817 (Pubitemid 350103057)
40. Danias PG, Papaioannou GI, Ahlberg AW, O'Sullivan DM, Mann A, Boden WE et al. Usefulness of electrocardiographic-gated stress technetium-99m sestamibi single-photon emission computed tomography to differentiate ischemic from nonischemic cardiomyopathy. Am J Cardiol 2004;94:14-19 (Pubitemid 38813446)
41. Danias PG, Ahlberg AW, Clark BA, 3rd, Messineo F, Levine MG, McGill CC et al. Combined assessment of myocardial perfusion and left ventricular function with exercise technetium-99m sestamibi gated single-photon emission computed tomography can differentiate between ischemic and nonischemic dilated cardiomyopathy. Am J Cardiol 1998;82:1253-1258
42. Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J Am Coll Cardiol 2009;53:426-435
43. Zoghbi GJ, Dorfman TA, Iskandrian AE. The effects of medications on myocardial perfusion. J Am Coll Cardiol 2008;52:401-416
44. Sharir T, Rabinowitz B, Livschitz S, Moalem I, Baron J, Kaplinsky E et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998;31:1540-1546 (Pubitemid 28273296)
45. Marie PY, Mercennier C, Danchin N, Djaballah K, Grentzinger A, Zannad F et al. Residual exercise SPECT ischemia on treatment is a main determinant of outcome in patients with coronary artery disease treated medically at long-term with beta-blockers. J Nucl Cardiol 2003;10:361-368 (Pubitemid 37045630)
46. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-1291
47. Mieres JH, Rosman DR, Shaw LJ. The role of myocardial perfusion imaging in special populations: women, diabetics, and heart failure. Semin Nucl Med 2005;35:52-61.
48. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-666 (Pubitemid 29116372)
49. Santana-Boado C, Candell-Riera J, Castell-Conesa J, Aguadé-Bruix S, García-Burillo A, Canela T et al. Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men. J Nucl Med 1998;39:751-755 (Pubitemid 28216717)
50. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997;29:69-77. (Pubitemid 27028722)
51. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 2005;111:682-696 (Pubitemid 40216498)
52. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32-40. (Pubitemid 34049139)
53. Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett E et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004;27:1954-1961 (Pubitemid 38989238)
54. Vanzetto G, Halimi S, Hammoud T, Fagret D, Benhamou PY, Cordonnier D et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999;22:19-26.
55. Shaw LJ, Berman DS, Hendel RC, Alazraki N, Krawczynska E, Borges-Neto S et al. Cardiovascular disease risk stratification with stress single-photon emission computed tomography technetium-99m tetrofosmin imaging in patients with the metabolic syndrome and diabetes mellitus. Am J Cardiol 2006;97:1538-1544
56. Venkataraman R, Hage FG, Dorfman T, Heo J, Aqel RA, de Mattos AM et al. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography. Am J Cardiol 2008;102:1451-1456
57. Siedlecki A, Foushee M, Curtis JJ, Gaston RS, Perry G, Iskandrian AE et al. The impact of left ventricular systolic dysfunction on survival after renal transplantation. Transplantation 2007;84:1610-1617
58. Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001;42:831-837 (Pubitemid 32537427)
59. Takahashi N, Reinhardt CP, Marcel R, Leppo JA. Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201Tl in a model of acute coronary reperfusion. Circulation 1996;94:2605-2613 (Pubitemid 26403592)
60. Levine MG, Ahlberg AW, Mann A, White MP, McGill CC, Mendes de Leon C et al. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging. J Nucl Cardiol 1999;6:389-396 (Pubitemid 29405960)
61. Duncan BH, Ahlberg AW, Levine MG, McGill CC, Mann A, White MP et al. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability. Am J Cardiol 2000;85:680-684 (Pubitemid 30133385)
62. Mabuchi M, Kubo N, Morita K, Makino Y, Matsui Y, Murashita T et al. Prediction of functional recovery after coronary bypass surgery using quantitative gated myocardial perfusion SPECT. Nucl Med Commun 2003;24:625-631
63. Sciagra R, Leoncini M. Gated single-photon emission computed tomography. The present-day "one-stop-shop" for cardiac imaging. Q J Nucl Med Mol Imaging 2005;49:19-29.
64. Leoncini M, Marcucci G, Sciagrà R, Frascarelli F, Bellandi F, Gallopin M et al. Usefulness of distinct activity thresholds according to baseline regional asynergy for predicting functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction: a study with nitrate-enhanced sestamibi gated SPECT. J Nucl Cardiol 2001;8:555-560 (Pubitemid 32982774)
65. Everaert H, Vanhove C, Franken PR. Low-dose dobutamine gated single-photon emission tomography: comparison with stress echocardiography. Eur J Nucl Med 2000;27:413-418 (Pubitemid 30225003)
66. Acampa W, Evangelista L, Sorrentino AR, Petretta M, Luongo L, Cuocolo A. Single-photon emission computed tomography after nitrate administration predicts cardiac events in patients with previous myocardial infarction and left ventricular dysfunction. J Card Fail 2007;13:765-768 (Pubitemid 350051971)
67. Solar M, Zizka J, Dolezal J, Klzo L, Tintera J, Vizda J et al. Contrast-enhanced magnetic resonance and thallium scintigraphy in the detection of myocardial viability: a prospective comparative study. Int Heart J 2006;47:521-532
68. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853 (Pubitemid 34603028)
69. Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289:2685-2694 (Pubitemid 37430139)
70. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-2150 (Pubitemid 38637994)
71. Cleland JG, Daubert JC, Erdmann E, Fruhwald F, Shankar A, Marijanowski M et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549 (Pubitemid 40517094)
72. Bax JJ, Abraham T, Barold SS, Breithardt OA, Fung JW, Garrigue S et al. Cardiac resynchronization therapy: Part 1 - issues before device implantation. J Am Coll Cardiol 2005;46:2153-2167 (Pubitemid 41785481)
73. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117:2608-2616
74. Chen J, Garcia EV, Folks RD, Sun JP, Nihoyannopoulos P, Merlino J et al. Onset of left ventricular mechanical contraction as determined by phase analysis of ECG-gated myocardial perfusion SPECT imaging: development of a diagnostic tool for assessment of cardiac mechanical dyssynchrony. J Nucl Cardiol 2005;12:687-95. (Pubitemid 43033609)
75. Trimble MA, Borges-Neto S, Smallheiser S, Chen J, Honeycutt EF, Shaw LK et al. Evaluation of left ventricular mechanical dyssynchrony as determined by phase analysis of ECG-gated SPECT myocardial perfusion imaging in patients with left ventricular dysfunction and conduction disturbances. J Nucl Cardiol 2007;14:298-307. (Pubitemid 46840298)
76. Trimble MA, Borges-Neto S, Honeycutt EF, Shaw LK, Pagnanelli R, Chen J et al. Evaluation of mechanical dyssynchrony and myocardial perfusion using phase analysis of gated SPECT imaging in patients with left ventricular dysfunction. J Nucl Cardiol 2008;15:663-670
77. Henneman MM, Chen J, Ypenburg C, Dibbets P, Bleeker GB, Boersma E et al. Phase analysis of gated myocardial perfusion single-photon emission computed tomography compared with tissue Doppler imaging for the assessment of left ventricular dyssynchrony. J Am Coll Cardiol 2007;49:1708-1714 (Pubitemid 46589921)
78. Marsan NA, Henneman MM, Chen J, Ypenburg C, Dibbets P, Ghio S et al. Left ventricular dyssynchrony assessed by two three-dimensional imaging modalities: phase analysis of gated myocardial perfusion SPECT and tri-plane tissue Doppler imaging. Eur J Nucl Med Mol Imaging 2008;35:166-173 (Pubitemid 350234139)
79. Chen J, Faber TL, Cooke CD, Garcia EV. Temporal resolution of multiharmonic phase analysis of ECG-gated myocardial perfusion SPECT studies. J Nucl Cardiol 2008;15:383-391
80. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972;15:289-329.
81. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981;23:321-336
82. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-1460 (Pubitemid 27486461)
83. Bax JJ, Visser FC, Blanksma PK, Veening MA, Tan ES, Willemsen TM et al. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. J Nucl Med 1996;37:1631-1636
84. Mabuchi M, Kubo N, Morita K, Noriyasu K, Itoh Y, Katoh C et al. Value and limitation of myocardial fluorodeoxyglucose single photon emission computed tomography using ultra-high energy collimators for assessing myocardial viability. Nucl Med Commun 2002;23:879-885 (Pubitemid 35052976)
85. Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram MY, Goodbody AE et al. Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation 2005;112:2169-2174
86. Kawai Y, Tsukamoto E, Nozaki Y, Morita K, Sakurai M, Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 2001;38:1888-94. (Pubitemid 33116560)
87. Kawai Y, Morita K, Nozaki Y, Ohkusa T, Sakurai M, Tamaki N. Diagnostic value of 123I-betamethyl-p-iodophenyl-pentadecanoic acid (BMIPP) single photon emission computed tomography (SPECT) in patients with chest pain. Comparison with rest-stress 99mTc-tetrofosmin SPECT and coronary angiography. Circ J 2004;68:547-552